PPARG and central nervous system cancer: Glioma cells overexpressing PPARγ-cDNA showed reduced cellular viability afterpioglitazone treatment, whereas treatment of glioma cells overexpressing amutant cDNA lacking transcriptional activity, showed no antineoplastic effects [52].